Protara Therapeutics (1KPA) Financial Statements
Protara Therapeutics Financial Overview
Protara Therapeutics's market cap is currently $131.23M. The company's EPS TTM is $-1.36; its P/E ratio is -1.82; Protara Therapeutics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -362.00K | $ 0.00 | $ -341.00K | $ 0.00 | $ 0.00 |
| Operating Income | $ -64.55M | $ -49.15M | $ -43.61M | $ -67.06M | $ -47.49M |
| EBITDA | $ -57.08M | $ -44.26M | $ -40.08M | $ -64.57M | $ -45.40M |
| Net Income | $ -57.44M | $ -44.60M | $ -40.42M | $ -65.95M | $ -47.25M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 155.55M | $ 170.29M | $ 65.58M | $ 84.37M | $ 91.23M |
| Total Assets | $ 209.47M | $ 181.45M | $ 78.95M | $ 113.29M | $ 172.60M |
| Total Debt | $ 3.36M | $ 4.48M | $ 5.47M | $ 6.38M | $ 7.24M |
| Net Debt | $ -46.30M | $ -158.31M | $ -34.12M | $ -17.74M | $ -28.48M |
| Total Liabilities | $ 13.06M | $ 14.32M | $ 10.63M | $ 11.21M | $ 10.68M |
| Stockholders' Equity | $ 196.41M | $ 167.13M | $ 68.32M | $ 102.08M | $ 161.91M |
| Cash Flow | |||||
| Free Cash Flow | $ -56.46M | $ -35.87M | $ -37.60M | $ -26.58M | $ -35.10M |
| Operating Cash Flow | $ -56.37M | $ -35.81M | $ -37.56M | $ -26.46M | $ -34.50M |
| Investing Cash Flow | $ -139.49M | $ 19.16M | $ 53.11M | $ 14.95M | $ -98.19M |
| Financing Cash Flow | $ 82.72M | $ 139.87M | $ -91.00K | $ -90.00K | $ -228.00K |
Currency in USD
